SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 205.55-1.3%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hippieslayer who wrote (14846)2/12/1998 1:24:00 PM
From: tonyt  Read Replies (1) of 32384
 
Ligand (NASDAQ:LGND) rises on positive data

==========================================================

LOS ANGELES, Feb 12 (Reuters) - Shares of Ligand
Pharmaceuticals Inc rose in active volume Thursday after the
release earlier in the week of positive data on two of the
company's leading drug candidates, analysts said.
They said they are particularly encouraged by a study
showing Ligand's Targretin drug for cancer was more effective
than the leading breast cancer drug on the market, in tests on
rats.
Shares of Ligand were up 1-1/4 to 14-5/8.
Ligand has Targretin in advanced clinical trials for
cutaneous t-cell lymphoma, a rare form of cancer, and is also
testing it in lung, ovarian, and head and neck cancer.
Van den Broek said the lymphoma indication for which Targretin
was most likely to win initial Food and Drug Administration
approval was a rare form of cancer, but positive data in other
more common types of cancers might lead to more off-label uses.
But some analysts questioned the usefulness of rat data.
"It always amazes me that people can get excited about rat
data since it is not really predictive of how a drug will work
in humans," said Americal Securities analyst Charles Engelberg.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News